Volume 2 Number 4

Website Exclusive Contents!
Exclusive contents: images and/or videos
• Anomalous origin of the right coronary artery from the mid left anterior descending artery
Sanghvi K, Devlin M, Hasan C, Coppola J
• Coronary-cameral fistula via multiple thin channels: diagnosis and characterisation by cine-loop ecg-gated 64-slice computed tomography
Martuscelli E, Mazzarotto P, Gemelli F, D’Eliseo A, Romeo F
• Late acquired stent malapposition after Sirolimus coronary stent implantation: a cause of late stent thrombosis?
Kay IP, Webster M, Ruygrok P, Stewart J, Ko A, Armstrong G, Ormiston J
Editorial
72
FDA panel, 7 and 8 December 2006 - The impact on our practice and research

Serruys PW

EuroInterv.2007;2:405-407

73
Where the soul lives

Holmes D

EuroInterv.2007;2:408-409

74
Drug eluting stents in left main stem stenosis: patients will pay the price

Taggart D

EuroInterv.2007;2:410-412

75
Current controversies in carotid artery stenting

Matsumura J, van Sambeek M

EuroInterv.2007;2:413-415

20 years of stenting
76
The balloon-expandable stent

Palmaz J

EuroInterv.2007;2:416-421

EAPCI column
77
The latest news from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)

Wijns W

EuroInterv.2007;2:423-425

Clinical research
78
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D, for the Nobori 1 Clinical Investigators

EuroInterv.2007;2:426-434

79
Revisiting the incidence and temporal distribution of cardiac and sudden death in patients undergoing elective intervention for unprotected left main coronary artery stenosis in the drug eluting stent era
A pooled analysis on 340 patients treated at three European referral centres

Valgimigli M, Chieffo A, Lefèvre T, Colombo A, Morice M-C, Serruys PW, on behalf of the Executive Committee of the Syntax Study

EuroInterv.2007;2:435-443

80
Endovascular therapy of chronic mesenteric ischaemia

Zeller T, Rastan A, Schwarzwalder U, Schwarz T, Frank U, Bürgelin K, Sixt S, Müller C, Rothenpieler U, Neumann F-J

EuroInterv.2007;2:444-451

81
Predicting coronary artery bypass graft surgery in acute coronary syndromes

Brieger D, Elsik M, Gore J, Knobel E, Nussbacher A, Piegas L, Allegrone J, Anderson F, Avezum A, on behalf of the Global Registry of Acute Coronary Events investigators (GRACE)

EuroInterv.2007;2:452-458

82
The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatation

Nienaber C, Hamm C, Weber F, Zeymer U, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Richardt G, Senges J, for the German Cypher Stent Registry

EuroInterv.2007;2:459-466

83
Advantage of sirolimus-eluting stents compared to intracoronary radiation therapy 30 months after treatment of in-stent restenosis

Iofina E, Gorchtein V, Radke P, Schubert D, Franke A, Langenberg R, Hanrath P, vom Dahl J, Hoffmann R

EuroInterv.2007;2:467-473

84
Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry

Varani E, Saia F, Balducelli M, Guastaroba P, Marrozzini C, Tarantino F, Passerini F, Sangiorgio P, Percoco G, Grilli R, Marzocchi A, Maresta A, for the REAL Investigators

EuroInterv.2007;2:474-480

85
The impact of age and Killip class on outcomes of primary percutaneous coronary intervention.
Insight from the PRAGUE-1 and -2 trials and registry

Widimsky P, Motovská Z, Bílková D, Aschermann M, Groch L, Zelízko M

EuroInterv.2007;2:481-486

86
Comparison of the in vitro performance of 6 and 7 French aspiration catheters

Hara H, Nakamura M, Komatsu H, Ikeda N, Shinji H, Makino K, Itaya H, Yamamoto M, Itou N, Tsunoda T, Sugi K

EuroInterv.2007;2:487-492

87
A simple risk score for prediction of mortality in patients undergoing percutaneous coronary intervention (PCI) for non-ST segment elevation acute coronary syndromes (NSTEACS)

Constantinides S, Osman F, Chit A, Halim M, Been M, Singh H, Glennon P, Fai Shiu M

EuroInterv.2007;2:493-499

Special report
88
True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar XL and the TandemHeart This article contains pictures and/or videos

de Jaegere P, van Dijk L, Laborde J-C, Sianos G, Orellana Ramos FJ, Ligthart J, Kappetein AP, van der Ent M, Serruys PW

EuroInterv.2007;2:500-505

Technical report
89
AXXESS™ Biolimus A9® eluting bifurcation stent system This article contains pictures and/or videos

Verheye S, Trauthen B

EuroInterv.2007;2:506-508

90
Abbott Vascular\'s everolimus eluting side branch access stent

Duchamp J, Boeke-Purkis K

EuroInterv.2007;2:509-511

Expert review
91
Late stent thrombosis: the Damocles' sword of drug eluting stents?

Rodriguez A, Rodríguez-Granillo G, Palacios I

EuroInterv.2007;2:512-517

92
Bifurcated stents: giving to Caesar what is Caesar\'s

Abizaid A, Alfaro V, Feres F, Staico R, Mattos L, Maldonado G, Eduardo Sousa J

EuroInterv.2007;2:518-525

93
The evolving role of coronary angiography and fluoroscopy in cardiac diagnosis and intervention This article contains pictures and/or videos

Gavit L, Carlier S, Hayase M, Burkhoff D, Leon M

EuroInterv.2007;2:526-532

Image in cardiology
94
Left ventricular angiogram in a patient with noncompaction cardiomyopathy This article contains pictures and/or videos

Caliskan K, de Visser R, van Geuns R-J, ten Cate F, Serruys PW

EuroInterv.2007;2:533-534

Volume 2 Number 4 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Boston Scientific
  • Cordis, a Johnson & Johnson company
  • Hexacath
  • Medtronic
  • Terumo

Online ISSN 1969-6213 - Print ISSN 1774-024X